Accelerating Global AMR Research Program

In this case study, discover how a European biotech partnered with Morula Health to streamline complex infectious disease medical writing across 15 projects, ensuring continuity, deep AMR expertise, and successful NDA‑ready submissions for a multi‑year global research program.

OVERVIEW

A European biotech organization sought a long-term partner to support its ambitious infectious disease R&D and clinical documentation needs.

Their mission was clear: deliver high-quality medical and scientific documents to accelerate drug development for AMR research.

CHALLENGE

They faced a significant challenge: managing a broad range of complex medical writing

deliverables across global programs without overburdening the internal teams.

Previous collaborations had resulted in high writer turnover and inconsistent expertise in

AMR. They needed a partner who could provide continuity, deep therapeutic knowledge, and

operational efficiency for a multi-year program culminating in regulatory approval.

SOLUTION

We assigned a dedicated pod of passionate writers specializing in infectious diseases,

ensuring familiarity and efficiency. The client’s satisfaction with the initial project led to

work spanning 15 projects over three years.

From clinical trial protocols and CSRs to manuscripts and regulatory appendices, every

document adhered to rigorous QC processes and timelines. By planning projects in

advance, the client was able to work with the same writer continuously, allowing us to

streamline workflows while maintaining full transparency and consistency throughout.

Get in touch to discuss how our experienced team and Medical Writers can support you: